Bristol Myers Squibb reported $1.93B in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US USD 2.69B 65M
Abbvie ABBV:US USD 3.3B 174M
Amgen AMGN:US USD 1.29B 40M
AstraZeneca AZN:LN USD 3.35B 280M
Astrazeneca AZN:US USD 3.35B 280M
Biogen BIIB:US USD 563.3M 9.3M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Catalent CTLT:US USD 196M 30M
Coherus Biosciences CHRS:US USD 44.83M 6.44M
Eli Lilly And LLY:US USD 1.61B 10.9M
Endo International Ordinary Shares ENDP:US USD 192.46M 10.92M
Gilead Sciences GILD:US USD 1.21B 144M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Horizon Pharma HZNP:US USD 397.56M 658K
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Johnson & Johnson JNJ:US USD 6.09B 137M
Lannett LCI:US USD 16.7M 9.06M
Medtronic MDT:US USD 2.56B 38M
Merk MRK:US USD 2.47B 13M
Novartis NOVN:VX USD 3.4B 185M
Perrigo Ordinary Shares PRGO:US USD 281M 57.1M
Pfizer PFE:US USD 3.54B 345M
Phibro Animal Health PAHC:US USD 54.96M 576K
Prestige Brands PBH:US USD 70.26M 3.59M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Revance Therapeutics RVNC:US USD 64.09M 17.91M
Teva Pharmaceutical Industries TEVA:US USD 777M 72M
United Therapeutics UTHR:US USD 98.4M 43.1M
Zoetis ZTS:US USD 501M 28M